Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
Market Access Collaboration is key to tackling geographical boundaries in ... Unlike most biopharmaceuticals, it is often a struggle to manufacture cell and gene therapies (CGTs) in disparate geographies.
Oncology CAR-TCR 2023 – Tim McGuire As the cell therapy world has heated up, so too has the world of cell and gene therapy contract manufacturing.
Partner Content Partner Content SpectronRx Receives U.S. Nuclear Regulatory Commission Mater... Leading Radiopharma CDMO Opens Second Location
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends